Worried You Missed the Nvidia Bandwagon? Here -2-
AMD is an example of a large company on the list that is expected to grow sales at a rapid clip through 2026, with a P/E that is lower than Nvidia's. AMD's P/E is also a bit lower than it was a year a
Unusual Options Activity: DXCM, ALB and Others Attract Market Bets, DXCM V/OI Ratio Reaches 53.3
EST Jun 14th Morning Delivery - In the last two hours of trading, 5 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Form 144 | DexCom(DXCM.US) Director Proposes to Sell 113.55K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $DexCom(DXCM.US)$ Director Heller Bridgette P intends to sell 1,000 shares of its common stock on Jun 14, with a total market value of approximately $113.55K. Source
Possible Bearish Signals With DexCom Insiders Disposing Stock
Those Who Invested in DexCom (NASDAQ:DXCM) Five Years Ago Are up 192%
While DexCom, Inc. (NASDAQ:DXCM) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 13% in the last quarter. But that doesn
Barclays Maintains DexCom(DXCM.US) With Hold Rating, Maintains Target Price $138
Barclays analyst Matt Miksic maintains $DexCom(DXCM.US)$ with a hold rating, and maintains the target price at $138.According to TipRanks data, the analyst has a success rate of 62.3% and a total aver
Peering Into DexCom's Recent Short Interest
DexCom's (NYSE:DXCM) short percent of float has fallen 29.84% since its last report. The company recently reported that it has 7.78 million shares sold short, which is 2.21% of all regular shares that
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $145
Wells Fargo analyst Larry Biegelsen maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $145.According to TipRanks data, the analyst has a success rate of 60.1% and a tota
Abbott Receives FDA Clearance for New Continuous Glucose Monitoring Systems
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Dexcom Inc. (NASDAQ:DXCM), a leading glucose monitor manufacturer, has enabled direct Apple Inc.'s (NASDAQ:AAPL) Watch connectivity for its G7 model in the United States.What Happened: The new feature
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
The Most Crowded Longs and Shorts in U.S. Med-Tech for May - UBS
Express News | DexCom Announced Today That The Dexcom G7 Continuous Glucose Monitoring System Now Connects Directly To Apple Watch In The United States
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch* in the U.S., giving users confidence even when their iPhone isn't with them† As the first and only CGM system that connects
DexCom (DXCM) Declines on Potential Competition for Stelo (Revised)
Shares of DexCom DXCM lost almost 3% on Jun 3, probably due to concerns about a rise in competition for its recently approved Stelo as the FDA approved a competing product.
Express News | Dexcom Secures Access To Dexcom ONE Sensor For 100,000 Type 2 Diabetes Patients In France; French Government Offers Full National Reimbursement For CGM Technology
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $150
Bernstein analyst Lee Hambright maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $150.According to TipRanks data, the analyst has a success rate of 69.7% and a total av
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in acc
DexCom (DXCM) Declines on Potential Competition for Stelo
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Nova Scotia becomes the latest province and territory to offer access to simple and easy-to-use diabetes management solutions, helping Canadians living with diabetes take control of their healthBURNAB
No Data